Infectious Diseases Discovery, Infectious Diseases Therapeutic Area, Janssen Research and Development, Beerse, Belgium.
Charles River Laboratories, Beerse, Belgium.
PLoS One. 2024 Aug 22;19(8):e0304063. doi: 10.1371/journal.pone.0304063. eCollection 2024.
Research on liver-related conditions requires a robust and efficient method to purify viable hepatocytes, lymphocytes and all other liver resident cells, such as Kupffer or liver sinusoidal endothelial cells. Here we describe a novel purification method using liver enzymatic digestion, followed by a downstream optimized purification. Using this enzymatic digestion protocol, the resident liver cells as well as viable hepatocytes could be captured, compared to the classical mechanical liver disruption method. Moreover, single-cell RNA-sequencing demonstrated higher quality lymphocyte data in downstream analyses after the liver enzymatic digestion, allowing for studying of immunological responses or changes. In order to also understand the peripheral immune landscape, a protocol for lymphocyte purification from mouse systemic whole blood was optimized, allowing for efficient removal of red blood cells. The combination of microbeads and mRNA blockers allowed for a clean blood sample, enabling robust single-cell RNA-sequencing data. These two protocols for blood and liver provide important new methodologies for liver-related studies such as NASH, hepatitis virus infections or cancer research but also for immunology where high-quality cells are indispensable for further downstream assays.
研究肝脏相关疾病需要一种强大且高效的方法来分离活的肝细胞、淋巴细胞和所有其他肝脏固有细胞,如枯否细胞或肝窦内皮细胞。在这里,我们描述了一种使用肝脏酶解的新型分离方法,随后进行下游优化的分离。与经典的机械肝脏破坏方法相比,使用这种酶解方案可以捕获固有肝脏细胞和活的肝细胞。此外,单细胞 RNA 测序表明,在肝脏酶解后进行下游分析时,淋巴细胞的数据质量更高,从而可以研究免疫反应或变化。为了了解外周免疫图谱,还优化了从小鼠系统全血中分离淋巴细胞的方案,能够有效地去除红细胞。微珠和 mRNA 阻断剂的组合允许获得清洁的血液样本,从而能够获得强大的单细胞 RNA 测序数据。这些用于血液和肝脏的两种方案为肝脏相关研究(如 NASH、肝炎病毒感染或癌症研究)提供了重要的新方法学,也为免疫学提供了新方法学,因为高质量的细胞对于进一步的下游检测是必不可少的。